Drug to Fix Faulty DNA Gets Go-Ahead in Landmark Move That May Alter Medicine Forever by Jenny Hope. MailOnline. November 2, 2012.
The drug, Glybera, is aimed at a rare inherited disorder that disrupts fat production in the body. This is the first gene therapy approved for Europe. Two other therapies have been approved for sale in China.
No comments:
Post a Comment